PLAT and Stroke: The current mainstay of treatment for ischemic stroke is thrombolytic reperfusion through tissue plasminogen activator (tPA) infusion, but the narrow therapeutic window and associated adverse effects have not eliminated stroke as a major cause of mortality and morbidity around the world [4].